China National Medicines abolishes supervisory board in governance overhaul

China National Medicines Corp is abolishing its supervisory board, with oversight functions transferring to the board of directors' audit committee. The governance restructuring requires comprehensive revisions to the company's articles of association and meeting procedures.

The company is also revising policies on external guarantees, profit distribution and senior management appointments to align with updated regulatory requirements.